Prudential Financial’s Haemonetics HAE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$643K Sell
8,567
-68,655
-89% -$4.41M ﹤0.01% 1819
2026
Q1
$4.35M Buy
77,222
+31,080
+67% +$2.02M 0.01% 979
2025
Q4
$3.7M Buy
46,142
+38,813
+530% +$2.61M ﹤0.01% 1036
2025
Q3
$357K Sell
7,329
-360
-5% -$22.3K ﹤0.01% 2052
2025
Q2
$574K Sell
7,689
-21,398
-74% -$1.42M ﹤0.01% 1890
2025
Q1
$1.85M Sell
29,087
-11,775
-29% -$801K ﹤0.01% 1317
2024
Q4
$3.19M Sell
40,862
-16,345
-29% -$1.31M ﹤0.01% 1073
2024
Q3
$4.6M Sell
57,207
-52,200
-48% -$4.22M 0.01% 1024
2024
Q2
$9.05M Sell
109,407
-67,887
-38% -$5.97M 0.01% 677
2024
Q1
$15.1M Buy
177,294
+4,978
+3% +$391K 0.02% 530
2023
Q4
$14.7M Buy
172,316
+10,879
+7% +$941K 0.02% 529
2023
Q3
$14.5M Buy
161,437
+1,943
+1% +$173K 0.02% 526
2023
Q2
$13.6M Buy
159,494
+3,028
+2% +$256K 0.02% 563
2023
Q1
$12.9M Buy
156,466
+45,855
+41% +$3.71M 0.02% 569
2022
Q4
$8.7M Buy
110,611
+19,676
+22% +$1.58M 0.01% 678
2022
Q3
$6.73M Sell
90,935
-42,407
-32% -$3.04M 0.01% 781
2022
Q2
$8.69M Sell
133,342
-64,850
-33% -$3.84M 0.01% 713
2022
Q1
$12.5M Buy
198,192
+142,930
+259% +$7.77M 0.02% 659
2021
Q4
$2.93M Buy
55,262
+35,664
+182% +$2.17M ﹤0.01% 1327
2021
Q3
$1.38M Sell
19,598
-1,019
-5% -$64.3K ﹤0.01% 1643
2021
Q2
$1.37M Sell
20,617
-14,832
-42% -$1.05M ﹤0.01% 1664
2021
Q1
$3.94M Buy
35,449
+27,983
+375% +$3.46M 0.01% 1125
2020
Q4
$886K Sell
7,466
-141
-2% -$15.2K ﹤0.01% 1808
2020
Q3
$664K Sell
7,607
-42,806
-85% -$3.74M ﹤0.01% 1840
2020
Q2
$4.52M Sell
50,413
-28,279
-36% -$2.86M 0.01% 1000
2020
Q1
$7.84M Sell
78,692
-67,018
-46% -$7.27M 0.02% 735
2019
Q4
$16.7M Sell
145,710
-17,665
-11% -$2.14M 0.02% 652
2019
Q3
$20.6M Sell
163,375
-29,964
-15% -$3.8M 0.03% 548
2019
Q2
$23.3M Sell
193,339
-244,464
-56% -$24.1M 0.04% 514
2019
Q1
$38.3M Buy
437,803
+32,624
+8% +$2.97M 0.06% 327
2018
Q4
$40.5M Buy
405,179
+116,450
+40% +$12.2M 0.07% 285
2018
Q3
$33.1M Buy
288,729
+22,853
+9% +$2.37M 0.05% 419
2018
Q2
$23.8M Buy
265,876
+19,129
+8% +$1.62M 0.04% 540
2018
Q1
$18.1M Buy
246,747
+97,591
+65% +$6.7M 0.03% 651
2017
Q4
$8.66M Buy
149,156
+58,264
+64% +$3.07M 0.01% 958
2017
Q3
$4.08M Buy
90,892
+1,600
+2% +$66.5K 0.01% 1235
2017
Q2
$3.53M Sell
89,292
-11,030
-11% -$453K 0.01% 1287
2017
Q1
$4.07M Sell
100,322
-3,090
-3% -$121K 0.01% 1212
2016
Q4
$4.16M Sell
103,412
-15,050
-13% -$567K 0.01% 1193
2016
Q3
$4.29M Sell
118,462
-79,470
-40% -$2.73M 0.01% 1139
2016
Q2
$5.74M Buy
197,932
+73,300
+59% +$2.22M 0.01% 1034
2016
Q1
$4.36M Buy
124,632
+6,400
+5% +$207K 0.01% 1163
2015
Q4
$3.81M Buy
118,232
+1,900
+2% +$61.6K 0.01% 1199
2015
Q3
$3.76M Sell
116,332
-1,500
-1% -$56.4K 0.01% 1163
2015
Q2
$4.87M Buy
117,832
+1,750
+2% +$73.8K 0.01% 1115
2015
Q1
$5.21M Sell
116,082
-1,900
-2% -$79.4K 0.01% 1122
2014
Q4
$4.42M Sell
117,982
-1,000
-0.8% -$36.6K 0.01% 1067
2014
Q3
$4.16M Sell
118,982
-4,214
-3% -$150K 0.01% 1046
2014
Q2
$4.35M Buy
123,196
+4,314
+4% +$144K 0.01% 1079
2014
Q1
$3.87M Buy
118,882
+1,500
+1% +$57.3K 0.01% 1105
2013
Q4
$4.95M Sell
117,382
-1,000
-0.8% -$41.2K 0.01% 977
2013
Q3
$4.72M Buy
118,382
+3,100
+3% +$130K 0.01% 968
2013
Q2
$4.77M Buy
+115,282
New +$4.67M 0.01% 927

Other funds holding HAE

Prudential Financial's HAE Position: Q2 2026 in Review

Prudential Financial reduced its Haemonetics (HAE) stake by 89% in Q2 2026, selling an estimated $4.41M and leaving 8,567 shares worth $643K. The position accounts for ﹤0.01% of the portfolio, ranked #1819.

Prudential Financial first reported a position in HAE in Q2 2013 and has held it in 53 quarters since. The position peaked at $40.5M in Q4 2018. 329 funds tracked by Wall St. Rank hold HAE as of Q2 2026.

  • Prudential Financial held 8,567 shares of Haemonetics worth $643K as of Q2 2026.
  • Prudential Financial sold 68,655 Haemonetics shares in Q2 2026, an estimated $4.41M.
  • Haemonetics made up ﹤0.01% of Prudential Financial's portfolio in Q2 2026, its #1819 holding.
  • Prudential Financial first reported a position in Haemonetics in Q2 2013 and has held it in 53 quarters since.
  • Prudential Financial's Haemonetics position peaked at $40.5M in Q4 2018.
  • 329 funds tracked by Wall St. Rank held Haemonetics as of Q2 2026.

Based on Prudential Financial's 13F filing for Q2 2026, filed 12 Aug 2026.